Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor

Igor Hudić, J. Szekeres-Barthó, Zlatan Fatušić, Babill Stray-Pedersen, Larisa Dizdarević-Hudić, Anela Latifagić, Nešad Hotić, Lejla Kamerić, Amer Mandžić

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Progesterone is indispensable in creating a suitable endometrial environment for implantation, and also for the maintenance of pregnancy. Successful pregnancy depends on an appropriate maternal immune response to the fetus. A protein called progesterone-induced blocking factor (PIBF) acts by inducing Th2-dominant cytokine production to mediate the immunological effects of progesterone. The aim of this prospective study was to compare serum concentrations of progesterone (P), estradiol (E2), anti-inflammatory (IL-10) and pro-inflammatory (IL-6, TNFα, IFNγ) cytokines, and serum PIBF concentrations in women with threatened preterm delivery who were given progesterone supplementation (study group) with those of women with threatened preterm delivery who were not given progesterone supplementation (control group). After dydrogesterone treatment of patients in the study group, serum PIBF as well as progesterone concentrations significantly increased. Women in this group had significantly higher serum levels of IL-10 than controls. The length of gestation was significantly higher in the group of women who were given progesterone supplementation. Our data suggest that dydrogesterone treatment of women at risk of preterm delivery results in increased PIBF production and IL-10 concentrations, and lower concentrations of IFNγ.

Original languageEnglish
Pages (from-to)103-107
Number of pages5
JournalJournal of Reproductive Immunology
Volume92
Issue number1-2
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Dydrogesterone
Progesterone
Hormones
Cytokines
Interleukin-10
Serum
blocking factor
Pregnancy Maintenance
Pregnancy

Keywords

  • Anti-inflammatory cytokines
  • Dydrogesterone
  • Preterm delivery
  • Pro-inflammatory cytokines
  • Progesterone
  • Progesterone-induced blocking factor

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. / Hudić, Igor; Szekeres-Barthó, J.; Fatušić, Zlatan; Stray-Pedersen, Babill; Dizdarević-Hudić, Larisa; Latifagić, Anela; Hotić, Nešad; Kamerić, Lejla; Mandžić, Amer.

In: Journal of Reproductive Immunology, Vol. 92, No. 1-2, 12.2011, p. 103-107.

Research output: Contribution to journalArticle

Hudić, Igor ; Szekeres-Barthó, J. ; Fatušić, Zlatan ; Stray-Pedersen, Babill ; Dizdarević-Hudić, Larisa ; Latifagić, Anela ; Hotić, Nešad ; Kamerić, Lejla ; Mandžić, Amer. / Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. In: Journal of Reproductive Immunology. 2011 ; Vol. 92, No. 1-2. pp. 103-107.
@article{87532cc8bf9f4e8ab768d34f73956417,
title = "Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor",
abstract = "Progesterone is indispensable in creating a suitable endometrial environment for implantation, and also for the maintenance of pregnancy. Successful pregnancy depends on an appropriate maternal immune response to the fetus. A protein called progesterone-induced blocking factor (PIBF) acts by inducing Th2-dominant cytokine production to mediate the immunological effects of progesterone. The aim of this prospective study was to compare serum concentrations of progesterone (P), estradiol (E2), anti-inflammatory (IL-10) and pro-inflammatory (IL-6, TNFα, IFNγ) cytokines, and serum PIBF concentrations in women with threatened preterm delivery who were given progesterone supplementation (study group) with those of women with threatened preterm delivery who were not given progesterone supplementation (control group). After dydrogesterone treatment of patients in the study group, serum PIBF as well as progesterone concentrations significantly increased. Women in this group had significantly higher serum levels of IL-10 than controls. The length of gestation was significantly higher in the group of women who were given progesterone supplementation. Our data suggest that dydrogesterone treatment of women at risk of preterm delivery results in increased PIBF production and IL-10 concentrations, and lower concentrations of IFNγ.",
keywords = "Anti-inflammatory cytokines, Dydrogesterone, Preterm delivery, Pro-inflammatory cytokines, Progesterone, Progesterone-induced blocking factor",
author = "Igor Hudić and J. Szekeres-Barth{\'o} and Zlatan Fatušić and Babill Stray-Pedersen and Larisa Dizdarević-Hudić and Anela Latifagić and Nešad Hotić and Lejla Kamerić and Amer Mandžić",
year = "2011",
month = "12",
doi = "10.1016/j.jri.2011.08.006",
language = "English",
volume = "92",
pages = "103--107",
journal = "Journal of Reproductive Immunology",
issn = "0165-0378",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor

AU - Hudić, Igor

AU - Szekeres-Barthó, J.

AU - Fatušić, Zlatan

AU - Stray-Pedersen, Babill

AU - Dizdarević-Hudić, Larisa

AU - Latifagić, Anela

AU - Hotić, Nešad

AU - Kamerić, Lejla

AU - Mandžić, Amer

PY - 2011/12

Y1 - 2011/12

N2 - Progesterone is indispensable in creating a suitable endometrial environment for implantation, and also for the maintenance of pregnancy. Successful pregnancy depends on an appropriate maternal immune response to the fetus. A protein called progesterone-induced blocking factor (PIBF) acts by inducing Th2-dominant cytokine production to mediate the immunological effects of progesterone. The aim of this prospective study was to compare serum concentrations of progesterone (P), estradiol (E2), anti-inflammatory (IL-10) and pro-inflammatory (IL-6, TNFα, IFNγ) cytokines, and serum PIBF concentrations in women with threatened preterm delivery who were given progesterone supplementation (study group) with those of women with threatened preterm delivery who were not given progesterone supplementation (control group). After dydrogesterone treatment of patients in the study group, serum PIBF as well as progesterone concentrations significantly increased. Women in this group had significantly higher serum levels of IL-10 than controls. The length of gestation was significantly higher in the group of women who were given progesterone supplementation. Our data suggest that dydrogesterone treatment of women at risk of preterm delivery results in increased PIBF production and IL-10 concentrations, and lower concentrations of IFNγ.

AB - Progesterone is indispensable in creating a suitable endometrial environment for implantation, and also for the maintenance of pregnancy. Successful pregnancy depends on an appropriate maternal immune response to the fetus. A protein called progesterone-induced blocking factor (PIBF) acts by inducing Th2-dominant cytokine production to mediate the immunological effects of progesterone. The aim of this prospective study was to compare serum concentrations of progesterone (P), estradiol (E2), anti-inflammatory (IL-10) and pro-inflammatory (IL-6, TNFα, IFNγ) cytokines, and serum PIBF concentrations in women with threatened preterm delivery who were given progesterone supplementation (study group) with those of women with threatened preterm delivery who were not given progesterone supplementation (control group). After dydrogesterone treatment of patients in the study group, serum PIBF as well as progesterone concentrations significantly increased. Women in this group had significantly higher serum levels of IL-10 than controls. The length of gestation was significantly higher in the group of women who were given progesterone supplementation. Our data suggest that dydrogesterone treatment of women at risk of preterm delivery results in increased PIBF production and IL-10 concentrations, and lower concentrations of IFNγ.

KW - Anti-inflammatory cytokines

KW - Dydrogesterone

KW - Preterm delivery

KW - Pro-inflammatory cytokines

KW - Progesterone

KW - Progesterone-induced blocking factor

UR - http://www.scopus.com/inward/record.url?scp=81555228578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81555228578&partnerID=8YFLogxK

U2 - 10.1016/j.jri.2011.08.006

DO - 10.1016/j.jri.2011.08.006

M3 - Article

C2 - 22032897

AN - SCOPUS:81555228578

VL - 92

SP - 103

EP - 107

JO - Journal of Reproductive Immunology

JF - Journal of Reproductive Immunology

SN - 0165-0378

IS - 1-2

ER -